Abstract:
Objective:To explore the main mechanism of caffeic acid phenethyl ester(CAPE)in the treatment of spinal cord injury(SCI)using the method of network pharmacology and test it experimentally.
Methods:The ac-tion targets of CAPE were obtained from SwissTargetPrediction, SEA, STITCH and TargetNet databases, and SCI related genes were obtained from GeneCards, Malacards, DrugBank, CTD and TTD databases.The protein interaction (PPI) network of overlapping genes was obtained from STRING online database and the core genes were screened by Cytoscape software.GO analysis and KEGG pathway enrichment analysis of overlapping genes were carried out by R software, the enrichment results were visualized and AutoDock software was used for molecular docking.Twenty-four SD rats were randomly divided into sham operation group, model group, lowdose CAPE group and high-dose CAPE group, with 6 rats in each group.The SCI rat model was established by modified Allen method.The motor function of hind limbs in rats was evaluated by Basso Beattie Bresnahan(BBB) score.Hematoxylin-eosin (HE) staining and Nissl staining were used to observe the structural in-tegrity of spinal cord tissue and neuronal survival.Re-al-time fluorescence quantitative polymerase chain re-action (RT-qPCR) was used to verify the expression levels of core targets in spinal cord tissue of rats after CAPE intervention.
Results:A total of 48 predictive targets for CAPE treatment of SCI were screened and
EG-FR,
JUN,
ESR1,
MMP9 and
PTGS2 were the core targets.GO analysis and KEGG analysis showed that CAPE treatment of SCI might be related to estrogen, HIF-1, VEGF and IL-17 signaling pathways.Molecular docking showed that CAPE had good binding to EGFR, JUN, ESR1, MMP9 and PTGS2 proteins.The results of animal experiments showed that the intervention of CAPE significantly increased the BBB score of SCI rats, and re-duced the structural damage of spinal cord tissue and neuronal injury in SCI rats.Compared with the model group, the expression levels of
JUN,
MMP9,
PTGS2 and
EGFR mRNA in low-dose CAPE group and high-dose CAPE group decreased, while the expression level of
ESR1 mRNA increased (all
P< 0.05).
Conclusion:CAPE may regulate the signaling pathways of estrogen, HIF-1, VEGF and IL-17 by down-regulating the
EGFR,
JUN, MMP9 and
PTGS2 gene expressions and up-regulating the
ESR1 gene expression, and then play a neuroprotec-tive role after SCI.